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The tetherin/BST2/CD317 protein blocks the release
of HIV-1 and other enveloped viruses by inducing
tetheringofnascentparticles to infectedcell surfaces.
The HIV-1 Vpu protein antagonizes the antiviral
activity of human but not monkey tetherins and
many simian immunodeficiency viruses (SIVs) do not
encode Vpu. Here, we show that the apparently
‘‘missing’’ antitetherin activity in SIVs has been
acquired by several SIV Nef proteins. Specifically,
SIVMAC/SIVSMM, SIVAGM, and SIVBLU Nef proteins can
suppress tetherin activity. Notably, tetherin antago-
nism by SIV Nef proteins is species specific, is genet-
ically separable from other Nef activities, and is most
evident with simian rather than human tetherin
proteins. Accordingly, a critical determinant of sensi-
tivity to SIVMAC Nef in the tetherin cytoplasmic tail is
variable in nonhuman primate tetherins and deleted
in human tetherin, likely due to selective pressures
imposed by viral antagonists, perhaps including Nef
proteins.
INTRODUCTION
The tetherin protein (also known as BST2 or CD317) is a potent
inhibitor of the release of enveloped viruses. It was recently iden-
tified as a factor in human cells that blocks release of HIV-1 parti-
cles from infected cells and is counteracted by the viral protein
Vpu (Neil et al., 2008; Van Damme et al., 2008). Its precise mech-
anism of action is not well defined at present, but in cells consti-
tutively expressing tetherin, protease-sensitive tethers retain
fully formed and mature HIV-1 particles on the cell surface and
tetherin colocalizes with puncta of Gag that likely represent
nascent virions (Jouvenet et al., 2009; Neil et al., 2006, 2007,
2008). Recently, we and others have shown that human tetherin
(hu-tetherin) has broad antiviral specificity and inhibits the
release of particles assembled using structural proteins from
all retroviruses tested, as well as filoviruses and arenaviruses
(Jouvenet et al., 2009; Kaletsky et al., 2009; Sakuma et al., 2009).54 Cell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc.The mechanism by which HIV-1 Vpu antagonizes hu-tetherin
is not fully understood, but overexpressed HIV-1 Vpu reduces
the overall levels of tetherin in cells and inhibits its appearance
at the cell surface (Bartee et al., 2006; Van Damme et al.,
2008). Furthermore, HIV-1 Vpu and hu-tetherin colocalize, and
Vpu prevents the colocalization of hu-tetherin with nascent
HIV-1 particles(Jouvenet et al., 2009; Neil et al., 2008). However,
while tetherin proteins from nonhominid primates are potent
inhibitors of HIV-1 particle release, they cannot be counteracted
by HIV-1 Vpu (McNatt et al., 2009). Portions of primate tetherin
genes, including sequences encoding the transmembrane
domain that governs sensitivity to antagonism by Vpu, are
unusually divergent and exhibit clear evidence of positive selec-
tion (McNatt et al., 2009). Thus, HIV-1 has apparently acquired
a biological activity (i.e., Vpu), that has specifically evolved to
antagonize the tetherin variant expressed in its host species.
Although hu-tetherin inhibits the release of particles assem-
bled using a diverse array of retroviral structural proteins, only
a subset of the primate lentiviruses encode Vpu. Thus, it seemed
reasonable to suppose that SIVs have evolved alternative mech-
anisms to evade tetherin in their natural hosts. Indeed, earlier
work indicated that the HIV-2 envelope protein could enhance
particle release from cells that were subsequently shown to
express hu-tetherin (Abada et al., 2005; Bour et al., 1996; Bour
and Strebel, 1996; Varthakavi et al., 2003). Given this precedent,
it was quite plausible that the envelope proteins of SIVs might
have a similar function. Consistent with this idea, the Ebola virus
envelope protein has recently been reported to be a tetherin
antagonist (Kaletsky et al., 2009).
However, as reported herein, we found that the envelope
protein of SIVMAC, a macaque lentivirus that is closely related to
HIV-2, did not antagonize macaque tetherin proteins. Rather,
Nef proteins from SIVMAC and several other SIVs antagonize
primate tetherins. Notably, tetherin antagonism by SIV Nef
proteinswasspecies specific, andeachSIVNefwaspoorly active
against human tetherin. Furthermore, the cytoplasmic tail of teth-
erin, which, like the transmembrane domain, has been evolving
underpositiveselection inprimates (McNatt et al., 2009), contains
a discrete motif that is deleted in humans and variable in other
primates and governs sensitivity to antagonism by SIVMAC Nef.
Thus, several primate lentiviruses that lack Vpu have acquired
the ability to antagonize tetherin using their Nef proteins.
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Inhibition of SIVMAC Particle Release by Tetherin
Proteins
Hu-tetherin can inhibit the release of particles assembled using
the structural proteins (Gag and/or GagPol) of a wide variety of
retroviruses (Jouvenet et al., 2009), raising the question of how
retroviruses that lack a Vpu gene are efficiently released from in-
fected cells that might ordinarily express tetherin. Among the
retroviruses previously tested for sensitivity to hu-tetherin were
the primate lentiviruses, SIVMAC and SIVAGMSab, neither of
which encode a Vpu protein (Jouvenet et al., 2009). However, it
has previously been shown that at least some strains of HIV-2,
a virus that shares a recent common ancestor with SIVMAC,
encode an envelope protein that has Vpu-like activity (Abada
et al., 2005; Bour et al., 1996; Bour and Strebel, 1996; Varthakavi
et al., 2003). Therefore, we tested whether the release of parti-
cles generated by a full-length SIVMAC239 proviral construct
could be inhibited by tetherin proteins found in macaque
species, specifically two variants from rhesus macaques (rh-
tetherin-1 and -2) and one from pig-tailed macaques (pgt-teth-
erin). Strikingly, each of the macaque tetherin proteins was a
rather poor inhibitor of SIVMAC239 particle release (Figure 1A).
This was the case whether or not the SIVMAC239 proviral DNA
construct encoded a functional Env protein. Thus, these results
suggested that SIVMAC239 might encode a tetherin antagonist
other than the Env protein.
Next we coexpressed an SIVMAC239 provirus with varying
amounts of human andmacaque tetherin proteins. As previously
shown for SIVMAC239 particles assembled using only the Gag and
Pol proteins, the release of authentic SIVMAC239 virions appeared
highly sensitive to hu-tetherin (Figures 1B and 1D). In contrast,
tetherin proteins from macaques appeared to be significantly
less effective inhibitors of SIV MAC239 virion release (Figures 1C,
1D, and S1).
These findings suggested the possibility that another SIVMAC
protein might be a macaque-tetherin-specific antagonist. The
ability of Nef to regulate the levels of cell-surface proteins
prompted us to examine whether it might fulfill this role. Strik-
ingly, the release of virions generated by a proviral plasmid lack-
ing Nef (SIVMAC239[delNef]) appeared more sensitive to inhibition
by macaque tetherins than SIVMAC239(WT) (Figures 1C, 1D, and
S1). In contrast, hu-tetherin inhibited SIVMAC239(WT) release
almost as well as it inhibited SIVMAC(delNef) release (Figures 1B
and 1D). Thus, Nef deletion specifically sensitized SIVMAC239 to
inhibition by macaque tetherins.
Scanning electron microscopic analysis of cells cotransfected
with plasmids expressing SIVMAC239 Gag and either rh-tetherin-1
or hu-tetherin revealed that either tetherin induced the accumu-
lation of SIVMAC239 VLPs on the surface of cells (Figure 1E).
Moreover, we have previously reported that HIV-1 Gag-GFP
VLPs tethered to the plasma membrane by hu-tetherin can be
internalized resulting in the accumulation of intracellular HIV-1
Gag-GFP (Neil et al., 2006, 2008), and similar findings were ob-
tained with SIVMAC239 Gag-GFP and rh-tetherin-1 (Figure 1F),
Specifically, in 293T cells stably expressing rh-tetherin-1, fluo-
rescencemicroscopic analysis indicated that nearly half the cells
transiently expressing SIVMAC239 Gag-GFP contained prominent
intracellular accumulations of Gag-GFP (Figures 1F and 1G).Crucially, these accumulations decreased in frequency when
increasing amounts of an SIVMAC239 Nef expression plasmid
were cotransfected, or when cells that did not express tetherin
were used (Figures 1F and 1G). Thus, macaque and human
tetherin proteins block particle release in the same manner,
and SIVMAC239 Nef antagonizes the tethering activity of macaque
tetherin.
Nef Proteins from Divergent Primate Lentiviruses
Antagonize Tetherin in a Species-Specific Manner
Vpu is present in only a minority of primate lentiviruses, while Nef
is present in all primate lentiviruses isolated thus far. Therefore,
to test whether Nef proteins from lentiviruses other than SIVMAC
might also be capable of counteracting tetherin, several of them
were expressed in place of HIV-1 Nef in the context of a replica-
tion-competent HIV-1 proviral construct. The HIV-1 Vpu protein
was inactivated in this construct, to test the effects of Nef on
particle release in the absence of confounding factors. Proviral
plasmids bearing the various Nef proteins were cotransfected
with increasing amounts of plasmids expressing hu-, rh-1-,
pgt-, and African green monkey (agm-) tetherin proteins.
Western blot analyses indicated proviruses expressing the
various Nef proteins generated HIV-1 virions with similar effi-
ciency in the absence of tetherins (Figures 2A–2H).
The generation of extracellular virions by cells transfected with
the parental proviral plasmid (which lacked both Nef and Vpu)
was strongly inhibited by each of the four tetherins (Figures 2A
and S2A), in the absence of effects on cell-associated Gag
expression. A matched HIV-1 provirus, which lacked Nef but re-
tained Vpu, was largely resistant to hu-tetherin. However, Vpu
did not antagonize agm-tetherin, rh-tetherin, or pgt-tetherin
(McNatt et al., 2009) (Figures 2B and S2B). A construct that
lacked Vpu but retained HIV-1 Nef behaved essentially the
same as the construct that lacked both Vpu and Nef (Figures
2C and S2C). Thus, HIV-1 Vpu specifically antagonized hu-teth-
erin but not monkey tetherins, while HIV-1 Nef did not antagonize
any of the tetherin proteins.
Notably, replacement of HIV-1 Nef with SIVMAC Nef resulted in
substantial resistance to both pgt- and rh-tetherin (Figures 2D
and S2D). Importantly, this effect was quite specific to the
macaque tetherins, and SIVMAC Nef only marginally enhanced
particle release when inhibition was imposed by hu-tetherin or
agm-tetherin. Conversely, SIVAGMSab Nef conferred a greater
degree of resistance to agm-tetherin than did SIVMAC Nef
(Figures 2E and S2E), and SIVAGMSab Nef was also active
against the macaque tetherins. However, SIVAGMSab Nef was
similar to SIVMAC Nef in that it was a poor antagonist of hu-teth-
erin (Figures 2E and S2E). Although this sample size is small, we
note that in the two cases examined where the parental viruses
lack a vpu gene (SIVMAC and SIVAGMSab), the Nef proteins
were able to antagonize the antiviral activity of tetherins found
in the corresponding simian host species.
We also tested Nef proteins from three other SIVs, with the
caveat that the SIV Nef proteins were not derived from the
same host species as the tetherins. Nonetheless, an HIV-1
proviral construct expressing the Nef protein from SIVBLU was
largely resistant to pgt-tetherin and rh-tetherin (Figures 2F and
S2F). Conversely, Nef proteins from SIVRCM and SIVGSN ap-
peared largely unable to antagonize the tetherin proteinsCell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc. 55
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that Nef and tetherin proteins from nonorthologous species were
tested, SIVGSN naturally encodes a Vpu protein (Courgnaud
et al., 2002), which potentially would obviate the requirement
for this activity in Nef. An additional caveat with the aforemen-
tioned experiment is that the SIV Nef proteins were expressed
in the Nef position of an HIV-1 provirus, and may be present at
higher or lower levels than in their parental proviruses. Addition-
ally, antibodies to the SIVRCM and SIVGSN proteins were not avail-
able, therefore we were unable to demonstrate that these Nef
proteins were expressed, although we have previously shown
that infection by nearly identical proviruses caused efficient
CD4 downregulation (Schindler et al., 2006). Nonetheless, three
of the five SIV Nef proteins tested in these assays exhibited
apparent tetherin antagonizing activity. The sensitivity or other-
wise of a given tetherin protein to antagonism by Nef did not
correlate with its expression level (Figure S3), which was as-
sessed under identical conditions to those used for the assays
in Figures 2 and S2.
To exclude the possibility the aforementioned findings were
the result of some unanticipated consequence of inserting
foreign nef genes into the HIV-1 genome in cis, we determined
whether Nef proteins, expressed in trans, would relieve tetherin
imposed blocks. A Vpu and Nef-defective HIV-1 proviral plasmid
was cotransfected with a fixed amount of each tetherin protein,
and varying amounts of plasmids expressing the Nef proteins
that exhibited apparent tetherin antagonizing activity (Figures 2
and S2). We also included HIV-1 Nef as a control, and an
additional SIVAGM Nef protein, from SIVAGMTan. As expected,
western blot and infectivity assays revealed that particle release
was strongly inhibited by each of the tetherin proteins, and
coexpression of HIV-1 Nef in trans had little, if any, ability to
relieve these tetherin-imposed blocks (Figures 3A and S4A).
Conversely, SIVMAC Nef relieved the inhibition of particle release
imposed by macaque tetherins, but its effect on particle release
in the presence of hu-tetherin or agm-tetherin was marginal
(Figures 3B and S4B). Both SIVAGMSab and SIVAGMTan Nef
restored particle release from cells expressing rh-, pgt-, or
agm-tetherin but were less active in relieving the block imposed
by hu-tetherin (Figures 3C, 3D, S4C, and S4D). Notably, these
two SIVAGM-derived proteins were the only Nef proteins thateffectively relieved inhibition by agm-tetherin. Finally, SIVBLU
Nef efficiently antagonized the macaque tetherin proteins, but
it also had some ability to enhance particle release in the pre-
sence of hu- and agm-tetherin (Figures 3E and S4E). However,
effects on hu-tetherin and agm-tetherin were clearly reduced in
magnitude as compared to effects on macaque tetherins. Over-
all, the effects of the various Nef proteins, expressed in trans, on
HIV-1 particle release corroborated those obtained when they
were expressed in cis. However, we were able to detect addi-
tional, albeit slight, anti-tetherin effects when Nef was expressed
in trans (for example, SIVBLU Nef slightly antagonized hu-tetherin
[Figure 3E]). We suspect that the small differences in results ob-
tained using the two assays reflect differences in the level of Nef
expression, which is likely higher when Nef is expressed in trans.
Notably, a modest degree of variation in the levels of expression
of the various tetherin proteins (Figure S5), assessed under iden-
tical conditions to those used in the assays in Figures 3 and S4,
did not correlate with the ability of a given tetherin protein to be
antagonized by Nef. Moreover, the Nef proteins that did not
antagonize tetherins (HIV-1 Nef) or Nef proteins that did antago-
nize monkey tetherins (SIVMAC239 Nef or SIVAGMTan Nef) did not
appear to inhibit expression of any of the tetherin proteins
(Figure S5).
The effects of Nef proteins on particle yield measured using
infectious virion yield assays correlated well with those assessed
using western blotting (Figure S4). However, in addition to their
tetherin antagonizing effects, each Nef protein tested enhanced
the intrinsic infectiousness of HIV-1 particles in the absence of
tetherins. Nonetheless, the tetherin-independent effect on virion
infectiousness was quite similar, and modest, irrespective of
which Nef protein was expressed (Figure S4). Together,
however, the compound effect of Nef proteins on particle release
and infectiousness, resulted in quite large effects on overall
infectious virion yield, approaching two orders of magnitude in
some cases.
SIV Nef Proteins Can Enhance Virion Release
from Simian Cells
If endogenously expressed monkey tetherins inhibit virion
release and are antagonized by SIV Nef proteins, thenNef should
enhance particle release from simian cells, particularly whenFigure 1. Effects of Env and Nef proteins on SIVMAC239 Particle Release
(A) Western blot analysis of wild-type (WT) and envelope deleted (del Env) SIVMAC239 particle release in the presence of tetherin-HA proteins from rhesus (rh) and
pig-tailed macaques (pgt). Cells were transfected with 400 ng of proviral plasmid and 40 ng of each tetherin expression plasmid. Cell and virion lysates were
probed with an anti-capsid monoclonal and/or rabbit anti-HA antibody, and signals detected using fluorescent secondary antibodies. The numbers below
each lane indicate quantitation (LICOR) of the p27CA present in the virion pellet.
(B and C) Western blot analysis of wild-type (WT) and Nef-deleted (del Nef) SIVMAC239 particle release in the presence of the hu-tetherin (B) or rh-tetherin-1 (C)
proteins. Cells were transfected with a fixed amount (400 ng) of proviral plasmid and varying amounts (50, 25, 12.5, 6.25, 3.12 or 0 ng) of each tetherin expression
plasmid. Cell and virion lysates were probed with an anti-capsid and anti-HA epitope monoclonal antibodies, and signals detected using chemiluminescence
reagents. The results shown are representative of at least three separate experiments.
(D) Quantitation of virion release inhibition by tetherin. P27CA in virion samples from (B) and (C) was measured using quantitative fluorescence-based western
blotting (LICOR).
(E) Representative scanning EM images of cells transfected with pSIVGag-IRESGFP and either no tetherin, rh-tetherin-1, or hu-tetherin. Cells were selected for
imaging based on similar levels of GFP fluorescence. Scale bar indicates 2 mm.
(F) Representative fluorescence micrographs of unmanipulated or rh-tetherin-1 expressing 293T cells transfected with plasmids expressing SIVMAC239 Gag-GFP
fusion protein, in the presence or absence of SIVMAC239 Nef.
(G) Quantitation of the proportion of cells displaying both plasma membrane and internal (PM + Int) or plasma membrane only (PM) intense accumulations of
SIVMAC239 Gag-GFP, under the same experimental conditions as in (F) (see F for examples). Cells were transfected with 0 (–), 0.8 (+), or 1.6 mg (++) of
pCR3.1/Nef. Values represent the mean ± SD of triplicate determinations and are representative of two independent experiments. At least 100 individual cells
were evaluated under each condition.Cell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc. 57
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Antagonism of Tetherin by SIV Nefthey are treated with IFNa, a known enhancer of tetherin expres-
sion. We first determined the effect of Nef on SIVMAC239 particle
release from rhesus macaque 221 T-cells in single cycle repli-
cation assays, following infection with VSV-G-pseudotyped
SIVMAC239(WT) or SIVMAC239(del Nef). Notably, 221 cells ex-
pressed tetherin in the absence of IFNa, and the levels of tetherin
mRNA were modestly increased by IFNa treatement
(Figure S6A). Western blotting analysis indicated that equiva-
lently infected cells release fewer SIVMAC239(del Nef) virions
than SIVMAC239(WT) virions, even though Gag was equally ex-
pressed (Figures 4A and S6B). This effect was exacerbated
when the infected 221 cells were treated with IFNa. Notably,
the discrepancy in particle release between SIVMAC239(WT) and
SIVMAC239(del Nef) was not observed when human 293T cells
were used in an otherwise identical single cycle replication assay
(Figures 4A and S6C). Thus, stimulation of particle release by Nef
was clearly host cell-type dependent. Notably, transmission
electron microscopic analysis of 221 cells revealed very obvious
accumulation of virions associated with the plasma membrane
of cells when they were infected with SIVMAC239 (delNef), but
not when they were infected with SIVMAC239(WT) (Figure 4B).
This phenotype was observed in otherwise untreated 221 cells
but was especially striking when the infected 221 cells were
treated with IFNa. Furthermore, these virions often appeared to
be tethered together (Figure 4B; [iv] inset), Thus, the inefficient
release of Nef-defective SIVMAC239 particles was accompanied
by accumulation of virions at the plasma membrane, recapitu-
lating previous observations of Vpu-defective HIV-1 virions in
hu-tetherin expressing human cells.
We also examined whether SIVAGMSab Nef could enhance
particle release from African green monkey COS-7 cells. In this
case, VSV-G pseudotyped HIV-1 constructs encoding either no
Nef, HIV-1 Nef, or SIVAGMSab Nef were used to infect COS-7
cells. Subsequent western blotting analysis indicated that
SIVAGMSab Nef significantly increased the yield of HIV-1 particles
from HIV-1 infected COS-7 cells, as compared to HIV-1 Nef or no
Nef (Figures 4C and S6D). Again this effect was present in the
absence of IFNa treatment, suggesting that COS-7 cells express
some tetherin, but was exacerbated by IFNa. Overall, both
SIVMAC239 and SIVAGMSab Nef proteins promoted particle release
and alleviated the accumulation of tethered virus particles at the
plasma membrane, in cells derived from relevant host species.
A Critical Determinant of Sensitivity to Antagonism
by SIVMAC Nef Is Variable in Monkey Tetherins
and Deleted in Hu-Tetherin
The amino-terminus of tetherin is the only portion of the protein
that is ordinarily exposed to the cell cytoplasm and was, there-
fore, the most likely determinant of sensitivity to antagonism by
SIV Nef proteins. We constructed two plasmids expressingCchimeric tetherins, in which the N termini of rh-tetherin and hu-
tetherin (residues 1–21 and 1–26, respectively) were reciprocally
exchanged, generating huCT-rh-tetherin and rhCT-hu-tetherin,
respectively (Figure 5A). Each of these chimeric tetherin proteins
inhibited the release of HIV-1 particles in the absence of Vpu or
Nef (Figure 5B). Notably, hu-tetherin and the huCT-rh-tetherin
chimera also inhibited the release of HIV-1 particles generated
by proviral plasmids that encoded SIVMAC239 Nef in cis, assessed
using both western blot or infectious virion assays (Figures 5B
and 5C). Conversely, the rhCT-hu-tetherin protein, like rh-teth-
erin, did not efficiently inhibit the generation of HIV-1 particles
generated in the presence of SIVMAC239 Nef. Similar experiments
showed that the release of Nef-defective SIVMAC239 virions was
inhibited by each of the intact and chimeric tetherins.
Conversely, the intact, Nef-expressing SIVMAC239 construct
was sensitive to inhibition by hu-tetherin and huCT-rh-tetherin,
but was resistant to the rhCT-hu-tetherin and rh-tetherin proteins
(Figures 5D and 5E). Thus, determinants in the cytoplasmic tails
of rh- and hu-tetherins govern their sensitivity and resistance,
respectively, to antagonism by SIVMAC Nef.
The cytoplasmic tails of rh-tetherins differ from hu-tetherin in
three short clusters of amino acids, including a 5 residue
sequence that is deleted specifically in the human lineage.
Therefore, we constructed three plasmids expressing hu-teth-
erin in which each variant amino acid cluster was substituted for
its equivalent in rh-tetherin-1; (hu[PIL], hu[KM], and hu[GDIWK];
Figure 6A). Each of these tetherin proteins was expressed and
inhibited the release of SIVMAC239(del Nef) virions with approxi-
mately equal efficiency, as assessed by western blotting assays
(Figures 6B and 6D). Moreover, hu(PIL) and hu(KM) tetherin
proteins efficiently inhibited the release of SIVMAC239(WT) virions
and were, thus, apparently insensitive to antagonism by
SIVMAC239 Nef (Figures 6C and 6D). Conversely, restoration of
the ‘‘missing’’ 5 amino acid GDIWKmotif in hu-tetherin conferred
sensitivity to antagonism by SIVMAC239 Nef. Indeed, hu(GDIWK)
was as sensitive to antagonism by SIVMAC239 Nef as was rhCT-
hu protein that encoded the complete rh-tetherin-1 cytoplasmic
tail (Figures 6C and 6D).
Thecytoplasmic tail of tetherinhasbeenevolvingunderpositive
selection, and the 5 residue motif that is deleted in humans
contains codons that exhibit a high probability of being positively
selected in other primate species (McNatt et al., 2009). Notably,
rh-tetherin-1 and rh-tetherin-2 differ at one amino acid within
this motif, encoding GDIWK and DDIWK, respectively (Fig-
ure S7A). Moreover, agm-tetherin, which is insensitive to antago-
nism by SIVMAC239 Nef (Figures 2 and 3), contains a single substi-
tution relative to rh-tetherin-2 tetherin at this motif and encodes
DDICK (Figure S7A). To further determine the role of this variable
motif in determining susceptibility to antagonism by SIVMAC239
Nef, we generated plasmids expressing rh-tetherin lacking thisFigure 2. Effects of Nef Substitution on HIV-1 Particle Release in the Presence of Human and Monkey Tetherin Proteins
(A–H) Western blot analysis of HIV-1 particle release. A fixed amount (200 ng) of each proviral plasmid was cotransfected with empty vector (none) or with
increasing amounts (3.12, 6.25, or 12.5ng, left to right) of African green monkey (agm), human (hu), pig-tailed macaque (pgt), or rhesus macaque (rh-1) teth-
erin-HA expression plasmids. Cell and virion lysates were probed with an anti-capsid monoclonal antibody. Proviral plasmids carrying neither Nef nor Vpu (A)
or HIV-1 Vpu (B) were used as controls. Thereafter, proviral plasmids lacking Vpu, but encoding HIV-1 Nef (C), SIVMAC Nef (D), SIVAGMSab Nef (E), SIVBLU Nef
(F), SIVRCM Nef (G), or SIVGSN Nef (H) were used. Samples derived from each viral construct were run on a single gel, and vertical lines are for visual guidance
only. Left panels are film images following detection using chemiluminescence reagents; right panels show the results of p24CA quantitation in virion samples
measured using quantitative fluorescence-based western blotting (LICOR). Results are from a single experiment and are representative of at least three separate
experiments.ell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc. 59
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Antagonism of Tetherin by SIV NefFigure 3. SIV Nef Proteins Expressed in trans Can Relieve Inhibition of HIV-1 Particle Release by Tetherins
(A–E) Western blot analysis of HIV-1 particle release. A fixed amount (200 ng) of each proviral plasmid was cotransfected with a fixed amount (12.5 ng)
of rhesus macaque (rh-1), pig-tailed macaque (pgt), human (hu), or African green monkey (agm) tetherin-HA expression plasmids, along with varying
amounts (0, 25, 50, and 100 ng) of HIV-1 Nef (A), SIVMAC Nef (B), SIVAGMSab Nef (C), SIVAGMTan Nef (D), or SIVBLU Nef (E) expression plasmids. Cell and
virion lysates were probed with an anti-capsid monoclonal antibody. Samples derived using each Nef protein were run on a single gel; vertical lines are60 Cell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc.
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Antagonism of Tetherin by SIV NefFigure 4. SIV Nef Proteins Can Enhance Virion Release and Relieve Virion Tethering in Simian Cells
(A) Rhesus macaque 221 cells and human 293T cells were infected with VSV-G pseudotyped SIVMAC239(WT) or SIVMAC239(del Nef), as indicated, at an MOI of 0.2
for 24 h, then washed and incubated with 0, 10, 100 or 1000 U/ml of IFNa for 24 hr. Cell and virion lysates were probed with anti-CA antibodies and signals
revealed using fluorescence detection (LICOR; see Figures S6A and S6B for quantitation).
(B) Rhesus macaque 221 cells were infected with VSV-G pseudotyped SIVMAC239(WT) (i and iii) or SIVMAC239(del Nef) (ii and iv), as indicated, at an MOI of 2 for
24 hr, then washed and incubated in the absence (i and ii) or presence (iii and iv) of 1000 U/ml of IFNa for 24 hr. Cells were then fixed and examined using trans-
mission electron microscopy. Scale bar = 500 nm. (iv) inset shows an expanded view of virions apparently tethered to each other.
(C) African green monkey COS-7 cells were infected with VSV-G pseudotyped HIV-1 encoding no Nef, HIV-1 Nef, or SIVAGMSab Nef, as indicated, at an MOI
of 1 for 24 hr, then washed and incubated with 0, 10, 100, or 1000 U/ml of IFNa for 24 hr. Cell and virion lysates were probed with anti-CA antibodies and
signals revealed using fluorescence detection (LICOR; see Figure S6C for quantitation of virion release). Results are representative of at least three independent
experiments.motif (rh[DGDIWK]), as well as single amino acid substitution
mutants (W17C) of rh-tetherin-1 and rh-tetherin-2 (rh-1[GDICK]
and rh-2[DDICK]). Notably, either the 5 amino acid deletion or
the single amino acid substitution, in the context of either the rh-
tetherin-1 or rh-tetherin-2, conferred resistance to antagonism
bySIVMAC239Nef (FiguresS7BandS7C). Thus,naturallyoccurring
deletions and substitutions within the same small motif, found in
humans and African green monkeys, can confer resistance to
antagonismbyNef proteins found in an SIV fromanother species.
Tetherin Antagonism Is Genetically Separable
from Other SIVMAC239 Nef Activities
We next determined whether mutations that specifically abolish
known biological activities of SIVMAC239 Nef affected its ability to
antagonize tetherin. As is the case with most other biological
activities of Nef proteins, mutation of the N-terminal myristate
acceptor (G2A) abolished the ability of SIVMAC239Nef to antago-
nize rh-tetherin (Figures 7A and 7B). Conversely, mutation ofa single residue (Y223F) that abolishes the ability of SIVMAC239
Nef to downregulate MHC-I but leaves other activities of
SIVMAC239 Nef, such as CD4 downregulation, intact (Schindler
et al., 2004) had little effect on tetherin antagonizing activity.
However, a series of threemutants that share the D204R substitu-
tion and have lost CD4 and CD28 downregulation activity, but
maintain MHC-I downregulation activity (Schindler et al., 2004),
were not effective rh-tetherin-1 antagonists (Figures 7A and 7B).
Notably, noneof thesemutations hadany effect onNef expression
levels (Schindler etal., 2004).Moreover, ananalysisoffivenaturally
occurring Nef proteins derived from the same lentivirus lineage as
SIVMAC239 revealed clear differences in tetherin antagonizing
activity (Figures 7C and 7D). Specifically, two SIVSMM-derived
Nef proteins were efficient rh-tetherin-1 antagonists, while two of
three HIV-2 Nef proteins were devoid of tetherin-antagonizing
activity and a third exhibited weak rh-tetherin-1-antagonizing
activity. Because these Nef proteins all share the ability to
downregulate CD4, MHC-I, and CD3 (Munch et al., 2005),for visual guidance only. Left panels are film images following detection using chemiluminescence reagents; right panels show the results of p24CA
quantitation in virion samples measured using quantitative fluorescence-based western blotting (LICOR). Results are from a single experiment and
are representative of at least three separate experiments.Cell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc. 61
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Antagonism of Tetherin by SIV NefFigure 5. The Cytoplasmic Tail of Tetherin Governs Sensitivity to Antagonism by SIVMAC Nef
(A) Schematic representation of the intact and chimeric tetherin proteins generated by exchange of sequences encoding the hu-tetherin and rh-tetherin cyto-
plasmic domains, generating huCT-rh-tetherin and rhCT-hu tetherin.
(B) A fixed amount of (500 ng) an HIV-1 proviral plasmid lacking both Vpu and Nef (upper panels) or lacking Vpu and encoding SIVMAC Nef (lower panels) was
transfected either alone ( lanes) or along with 50 ng of each intact or chimeric tetherin-HA expression plasmid depicted in (A) (+ lanes). The panels showwestern
blots of cell and virion lysates probedwith anti-capsid or anti-HAmonoclonal antibodies, and detectionwith chemiluminescence based reagents. Numbers below
each lane represent measurements of virion associated p24 measured using quantitative fluorescent western blotting (LICOR).
(C) An HIV-1 proviral plasmid carrying SIVMAC Nef (500 ng) was cotransfected with increasing amounts (0, 50, 100, or 200 ng) of each tetherin expression plasmid
depicted in (A). Infectious virion yield was measured as in Figure 3. Results are the mean ± SD of tripicate determinations from a single experiment and are repre-
sentative of three independent experiments.
(D) Western blot analysis of SIVMAC239(WT) and SIVMAC239 (delNef) particle release in the presence of the intact and chimeric tetherin-HA proteins. Cells were
transfected with a fixed amount (500 ng) of each SIVMAC239 proviral plasmid and varying amounts (0, 50, and 100ng) of each tetherin expression plasmid. The
panels show western blots of cell and virion lysates probed with anti-capsid or anti-HA monoclonal antibodies, and detection with chemiluminescence based
reagents. Numbers below each lane represent measurements of virion associated p27 measured using quantitative fluorescent western blotting (LICOR).
(E) An SIVMAC239(WT) proviral plasmid was cotransfected with increasing amounts (0, 13, 25, 50, 100, or 200 ng) of each intact or chimeric tetherin expression
plasmid depicted in (A). Infectious virion yield in the culture supernatant was measured as in Figure 3. Results are the mean ± SD of tripicate determinations from
a single experiment and are representative of three independent experiments.62 Cell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc.
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Antagonism of Tetherin by SIV NefFigure 6. Insertion of a ‘‘Missing’’ Five Amino Acid Sequence in Hu-Tetherin Confers Sensitivity to Nef Antagonism
(A) Alignment of the cytoplasmic tails of hu-tetherin and rh-tetherin-1 N-terminal cytoplasmic tails with differences in rh-tetherin-1 highlighted. Also shown are the
three mutant hu-tetherin constructs that were used.
(B) Western blot analysis of the expression of the mutant hu-tetherin proteins and inhibition of SIVMAC239(del Nef) particle release. Cells were transfected with
a fixed amount (500 ng) of proviral plasmid and 0, 12.5, 25, 50, 100 or 200 ng of each tetherin expression plasmid. Blots of cell lysates were simultaneously probed
with rabbit anti-HA and (upper panels) and anti-CA monoclonal antibodies (middle panels). Lysates of pelleted virions were probed with anti-CA antibodies only.
Signals were detected using fluorescent detection reagents (LICOR).
(C) Same as (B), except that SIVMAC239(WT) was used in place of SIVMAC239(del Nef).
(D) Quantitative analysis of virion associated p27CA, determined using the western blots shown in (B) for SIVMAC239(del Nef) and (C) for SIVMAC239(WT). Results are
representative of at least three independent experiments.Cell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc. 63
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Antagonism of Tetherin by SIV NefFigure 7. Effects of Introduced Mutations and Natural Variation in the SIVMAC/SIVSMM/HIV-2 Nef Proteins on Rh-Tetherin-1 Antagonism
(A) Cells were transfected with 400 ng of an HIV-1 proviral plasmid lacking Nef and Vpu, along with 25 ng of the rh-tetherin expression plasmid and 100 ng of each
WT or mutant SIVMAC239 Nef expression plasmid. Blots of cell lysates were simultaneously probed with rabbit anti-HA (upper panels) and anti-CA monoclonal
antibodies (middle panels). Lysates of pelleted virions were probed with anti-CA antibodies only (lower panels). Signals were detected using quantitative fluo-
rescent western blotting (LICOR), and numbers below each lane represent measurements of virion associated p24.
(B) Cells were transfected as in (A) and the yield of infectious virions in the culture supernatant wasmeasured using TZMbl indicator cells. Measurements are given
in relative light units (RLU) following detection of b-galactosidase expression using a chemiluminescent assay. Results are the mean ± SD of tripicate determi-
nations from a single experiment and are representative of two independent experiments.
(C) Cells were transfectedwith 400ngof anHIV-1 proviral plasmid lackingNef andVpu, alongwith 25ngof the rh-tetherin expression plasmidand 50ngof eachHIV-2,
SIVSMMorSIVMAC239Nefexpressionplasmid.Blotswereprobedandanalyzedas in (A)andnumbersbeloweach lanerepresentmeasurementsof virionassociatedp24.
(D) Cells were transfected as in (C), and the yield of infectious virions in the culture supernatant was measured as in (B). Results are the mean ± SD of tripicate deter-
minations from a single experiment and are representative of two independent experiments.these data show that tetherin antagonism is genetically separable
from several known biological activities of Nef, but may share
somemechanistic properties with CD4 downregulation. Addition-
ally, these data hint that natural variation in the ability of closely
related Nef proteins to act as tetherin antagonists may be
influenced by the host species in which the corresponding virus
replicates.64 Cell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc.DISCUSSION
Here we report that Nef proteins can enhance virion particle
release via antagonism of tetherin proteins. Notably, this activity
was not present in HIV-1 Nef, but five out of seven SIV Nef
proteins tested, from five different SIV lineages, exhibited teth-
erin-antagonizing activity. Importantly, thisNef function exhibited
Cell Host & Microbe
Antagonism of Tetherin by SIV Nefstriking species specificity; none of the SIV Nef proteins were
highly active against hu-tetherin, but in both cases where tether-
ins and Nef proteins were derived from the same host species
(macaque and agm), efficient antagonism was observed.
Previously, we showed that the HIV-1 Vpu protein also antag-
onizes tetherins in a species-specific manner. Determinants
of sensitivity to Vpu reside in the hu-tetherin transmembrane
domain, which exhibits a strong signature of positive or diversi-
fying selection, suggesting the possibility that Vpu, or a similar
viral antagonist of tetherin, has imposed selective pressure on
thisportion of the tetherin gene.Notably,wealsoobserved signa-
tures of positive selection in sequences encoding the tetherin
N-terminal cytoplasmic tail (McNatt et al., 2009).Obviously, given
the finding that the cytoplasmic tail of tetherin can determine
sensitivity or resistance to antagonism by SIVMAC Nef, then Nef
proteins are reasonable candidates for antagonists that impose
diversifying selection pressure on this tetherin domain.
The mechanism by which SIV Nef proteins antagonize tether-
ins remains to be determined. Preliminary experiments did not
reveal a clear effect of SIVMAC or SIVBLU Nef proteins on rh-teth-
erin cell-surface expression (data not shown). Nonetheless, HIV-1
and SIV Nef proteins downregulate several other cell surface
proteins, most notably CD4 and MHC-I (Collins et al., 1998; Gar-
cia and Miller, 1991; Schindler et al., 2006; Schwartz et al., 1996;
Stumptner-Cuvelette et al., 2001), by recruiting these receptors
to the endocytic machinery or by redirecting them to lysosomes
(reviewed in Kirchhoff et al., 2008; Roeth and Collins, 2006). The
HIV-1 Vpu protein excludes tetherin from sites of particle
assembly at the plasma membrane and inhibits cell surface
expression of tetherin (Jouvenet et al., 2009; Van Damme
et al., 2008). However, further work will be required to determine
precisely how antagonism of tetherin function by Nef and Vpu
proteins is achieved.
The ability to antagonize tetherin has apparently arisen at least
twice, perhaps three times during the evolution of primate lenti-
viruses, and strikingly the acquisition of this function has
occurred in completely different ways, employing Nef, Vpu,
and perhaps Env proteins. Of interest is the fact that both Nef
and Vpu proteins, to varying degrees, remove or antagonize
molecules (CD4 and tetherin) that are both capable of inhibiting
the release of infectious viral particles from the cell surface
(Lama et al., 1999; Ross et al., 1999). Moreover, both appear
to be multifunctional proteins whose activities partially coincide.
Overall these findings underscore the functional plasticity of
primate lentiviral genomes in general, and vpu and nef genes in
particular.
While the ability of Vpu andNef proteins to antagonize tetherin is
clearly demonstrable, it remains unproven that these activities are
critical in vivo. SIVMAC239 chimeras that encode HIV-1 Nef, and
therefore lack a predicted tetherin antagonist, are less pathogenic
than intact SIVMAC239, but are capable of causing simian AIDS in
some animals (Alexander et al., 1999; Kirchhoff et al., 1999).
Thus, tetherinantagonismmightnotbeessential for pathogenesis.
However, given the plasticity of Nef function it will be interesting to
determine whether HIV-1 Nef can acquire tetherin antagonizing
activity during SIVMAC239/SHIV replication in vivo. Additionally,
HIV-1 Vpu, despite lacking the ability to antagonizemacaque teth-
erins, enhances replication in the context of SHIV infection of pig-
tailed macaques (Stephens et al., 2002). Thus, other functions ofCVpu and Nef may be critical in vivo. Nonetheless, the independent
acquisition of tetherin-antagonizing activity that is specific to the
host species of a given HIV/SIV by Nef and Vpu strongly suggests
that these activities confer a selective advantage in vivo.
Finally, we note that three of the five known ‘‘nonessential’’
accessory genes in primate lentiviruses, namely vif, vpu,and
nef, are now demonstrated to encode antagonists of innate or
intrinsic immunity. Overall, these findings emphasize the extent
to which intrinsic and innate host defenses are likely to have
imposed evolutionary pressure on primate lentiviruses, influ-
enced species tropism and provided the impetus for the acqui-
sition of new genes and biological activities to enable immuno-
deficiency virus replication in an intrinsically hostile environment.
EXPERIMENTAL PROCEDURES
Plasmid Construction
Plasmids expressing the various HA-epitope-tagged tetherin proteins were
constructed as previously described (Jouvenet et al., 2009; McNatt et al.,
2009) using the cDNA sequences and oligonucleotides listed in Table S1.
Two variants of rhesus macaque tetherin were used (rh-1 and rh-2) that differ
at a single amino acid position in the cytoplasmic tail. No functional difference
between the two variants was detected, and the variants were used inter-
changeably.Mutant human and rhesus tetherinswere generated by PCR using
long oligos directed to the 50 end of the coding sequence (Table S1). To
generate the SIVMAC proviral clones used in this study, the full-length sequence
of SIVMAC239 was assembled from plasmids p239SpSp5
0 and p239SpE30 (Kes-
tler et al., 1990) (NIH AIDS Reagent Program) into a low copy number (pXF3)
backbone. For the SIVMAC(delNef) derivative of this clone, overlapping primers
and PCRwere used to introduce premature stop codon at codons 58 and 59 of
Nef, immediately 30 to the Env stop codon, using the primers listed in Table S2.
HIV-1-based proviral plasmids expressing Nef proteins from various lentivi-
ruses have been previously described (Munch et al., 2007; Schindler et al.,
2006). To generate vpu-defective derivatives thereof, restriction fragments en-
compassing the nef region were cloned into pBRHIV-1NL4-3Dvpu containing
a deletion of nucleotides 3–120 of the vpu coding frame. For the experiments in
which Nef proteins were expressed in trans, Nef coding sequences fromHIV-1,
SIVMAC239, SIVBLU, SIVAGMSab, and SIVAGMTan were amplified by PCR using
primers introducing EcoRI and SalI sites at the 50 end and 30 end of the coding
sequence respectively (Table S2). The PCR products were inserted into the
pIRES2-GFP expression vector (Clontech). SIVMAC239 Nef was also inserted
into pCR3.1. pCG-IRESGFP vectors expressing the SIVMAC239 mutant,
HIV-2, and SIVSMM Nef proteins used in Figure 7 have been described previ-
ously (Schindler et al., 2004).
Cell Lines and Transfection
293T and TZMbl cells (which express CD4 and CCR5 and contain a lacZ
reporter gene under the control of an HIV-1 LTR) were maintained under stan-
dard conditions. All transfection experiments were performed in 293T cells,
which do not constitutively express tetherin, that were seeded in 24-well plates
at a concentration of 2.5 3 105 cells/well and transfected the following day
using polyethylenimine (PolySciences). A 293T-derived cell line stably ex-
pressing rh-tetherin was derived by inserting the rh-tetherin-1 cDNA into
a retroviral vector (LHCX) that was then used to transduce 293T cells, which
were then selected in hygromycin.
Tomeasure tetherin inhibition of SIVMAC239 particle release, cells were trans-
fected with 400 ng of an SIVMAC239 proviral plasmid or the SIVMAC (delNef)
derivative, along with increasing amounts (3.12, 6.25, 12.5, 25, or 50 ng) of
each tetherin-HA expression plasmid. In some experiments (Figure 5), the
amount of SIVMAC proviral plasmid DNA was increased to 500 ng and the
amounts of tetherin plasmid were increased (to 0, 12.5, 25, 50, 100, 200 ng/
well). For assays using the HIV-1 proviral plasmids encoding various SIV Nef
proteins, cells were transfected with 200 ng of each proviral plasmid and
varying amounts (0, 3.12, 6.25, or 12.5 ng) of each tetherin-HA plasmid. Alter-
natively, 500 ng of HIV-1 proviral plasmid and 0, 50, 100, and 200 ng of tetherin
expression plasmid were used.ell Host & Microbe 6, 54–67, July 23, 2009 ª2009 Elsevier Inc. 65
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fected with 400 ng of the HIV-1 proviral plasmid that lacked both Nef and
Vpu, along with 25 ng of each tetherin-HA expression plasmid and varying
amounts (0, 25, 50, or 100 ng) of each HIV-1 or SIV Nef expression plasmid.
In all transfection experiments, the total amount of DNA was held constant
within the experiment by supplementing the transfection with empty expres-
sion vector.
To generate the VSV-G pseudotyped viruses in Figure 4, 10 mg of proviral
construct and 2 mg of VSV-G expression plasmid were used to transfect
a 10 cm dish of 293T cells. Viral stocks were titered on TZMbl indicator cells.
Virus Release Assays and Infectivity Assays
At 48 hr posttransfection, virion containing culture supernatants were har-
vested, clarified by low-speed centrifugation and filtered (0.2 mm). Infectious
virus release was determined by inoculating TZMbl indicator cells, plated the
previous day in 96-well plates at 83 103 cells/well, with 50 ml of serially diluted
supernatants. At 48 hr after infection, b-galactosidase activity was determined
using GalactoStar reagent (Perkin Elmer). The remainder of the virion contain-
ing supernatant (750 ml) was layered onto 400 ml of 20% sucrose in PBS and
centrifuged at 20,000 g for 2 hr at 4C. Virion pellets and corresponding virion
producing cells were dissolved in SDS-PAGE loading buffer. Virion and cell
lysates were separated on 4%–12% acrylamide gels, blotted onto nitrocellu-
lose membranes, and probed with anti-HIV-1-p24CA (183-H12-5C, which
also recognizes SIVMAC239 p27CA) or anti-HA (Covance) monoclonal anti-
bodies. Subsequently, blots were probed with anti-mouse HRP-conjugated
goat secondary antibodies (Jackson), and proteins revealed using chemilumi-
nescence detection reagents (Pierce). Alternatively, for quantitative western
blotting, blots were simultaneously or individually probed with anti-CA and
rabbit anti-HA antibodies, followed by goat anti-rabbit and anti-mouse anti-
bodies conjugated to IRDye680 and IRDye800CW, respectively. Fluorescent
signals were detected and quantitated using a LICOR Odyssey scanner.
Microscopy
Cells were seeded on 3.5 cm, glass-bottomed dishes coated with poly-L-
lysine (Mattek). The following day, they were transfected with 1.6 mg of
a mixture of plasmids expressing untagged SIVMAC239 Gag and SIVMAC239
Gag-GFP, along with 1.6 mg of empty pCR3.1 or pCR3.1/SIVMAC239 Nef, using
Lipofectamine 2000. Cells were fixed 24 hr later and observed by deconvolu-
tion microscopy using an Olympus IX70-based Deltavision microscopy suite
(Tokyo, Japan) as described previously (Neil et al., 2006). For transmission
electron microscopy studies, 221 cells were fixed 48 hr postinfection, using
4% paraformaldehyde, for 10 min. Cells were then pelleted by centrifugation
and processed for electron microscopy as described previously (Neil et al.,
2006). Alternatively, HT1080 cells were cotransfected with 200 ng each of
a plasmid expressing a codon optimized SIV Gag-IRES GFP cassette and
either rh-tetherin-1 or hu-tetherin expression plasmids inspected by fluores-
cent and scanning electron microscopy using a Hitachi S4700 field emission
SEM (University of Missouri Electron Microscopy Core Facility) as described
previously (Zhadina et al., 2007).
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